1. Langeh, Urvashi, Singh, Shamsher. . Targeting S100B Protein as a Surrogate Biomarker and its Role in Various Neurological Disorders. In Current neuropharmacology, 19, 265-277. doi:10.2174/1570159X18666200729100427. https://pubmed.ncbi.nlm.nih.gov/32727332/
2. Wu, Ke-Jia, Wang, Wanhe, Wang, Hui-Min David, Leung, Chung-Hang, Ma, Dik-Lung. 2020. Interfering with S100B-effector protein interactions for cancer therapy. In Drug discovery today, 25, 1754-1761. doi:10.1016/j.drudis.2020.07.010. https://pubmed.ncbi.nlm.nih.gov/32679172/
3. Gayger-Dias, Vitor, Vizuete, Adriana Fk, Rodrigues, Letícia, Kleindienst, Andrea, Gonçalves, Carlos-Alberto. 2023. How S100B crosses brain barriers and why it is considered a peripheral marker of brain injury. In Experimental biology and medicine (Maywood, N.J.), 248, 2109-2119. doi:10.1177/15353702231214260. https://pubmed.ncbi.nlm.nih.gov/38058025/
4. Kroksmark, Hilda, Vinberg, Maj. 2018. Does S100B have a potential role in affective disorders? A literature review. In Nordic journal of psychiatry, 72, 462-470. doi:10.1080/08039488.2018.1472295. https://pubmed.ncbi.nlm.nih.gov/29764272/